N. Nagai et al., SUPPRESSIVE EFFECT OF VASOPRESSIN ON THE HYPERGLYCEMIC RESPONSE TO INTRACRANIAL INJECTION OF 2-DEOXY-D-GLUCOSE, Neuroscience letters, 190(3), 1995, pp. 187-190
Vasopressin (VP) is a peptide consisting of 9 amino acids which acts a
s a neurotransmitter or neuromodulator in the central nervous system.
Neurons containing VP project to some nuclei in the hypothalamus that
have a role in energy metabolism. To clarify the possible role of VP o
n glucose metabolism in the brain, we examined the effect of intracran
ial injection of VP on the hyperglycemia induced by 2-deoxy-D-glucose
(2DG) and obtained the following results. The hyperglycemic and hyperg
lucagonemic responses induced by 2DG were significantly suppressed and
enhanced by co-injections of VP and a VP-antagonist with 2DG, respect
ively. However, co-injections of either VP or a VP-antagonist with 2DG
had no effect on the change in plasma insulin concentration. These fi
ndings suggest that central VP plays a suppressive role in the hypergl
ycemic and hyperglucagonemic responses to 2DG.